CS268082B1 - Biologically active esters with pyrethroid component in molecule and method of their preparation - Google Patents
Biologically active esters with pyrethroid component in molecule and method of their preparation Download PDFInfo
- Publication number
- CS268082B1 CS268082B1 CS8732A CS3287A CS268082B1 CS 268082 B1 CS268082 B1 CS 268082B1 CS 8732 A CS8732 A CS 8732A CS 3287 A CS3287 A CS 3287A CS 268082 B1 CS268082 B1 CS 268082B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- molecule
- formula
- biologically active
- symbol
- active esters
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Přední Stem řešení Jsou nové biologicky účinné estery s pyrethroidní složkou v molekule obecného vzorce I, kde symbol R1 značí alkylekuplnu s rovným čl rozvětveným řetězcem s maximálně 4 atomy uhlíku, R značí skupinu Ia nebo skupinu Ib a X značí halogen (chlor brom). Jejich posticidní účinky byly vyzkoušeny například na hmyzu a roztočích. Způsob přípavy látek obecného vzorce I, spočívá v reakci hydroxyslóučenlny obecného vzorce II, kde symbol R , R má výše uvedený význam za přítomnosti 4-dimethylaminopyrldlnu a dicyklohexylkargodllmidu při teplotě 10 až 20 C nebo s chloridem či anhydridem organické kyseliny za přítomnosti bezvodného pyridinu při 20 až 60 °C.Leading Stem Solutions Are New Biologically active esters with a pyrethroid component in the molecule of formula I, wherein the symbol R1 denotes an alkyl group with a straight line with a branched chain with a maximum of 4. \ t carbon atoms, R represents Ia or Ib and X are halogen (chloro) bromine). Their posticidal effects were for example on insects and mites. Method of preparation of general substances of formula (I), consists in the reaction of a hydroxybenzoate of formula II wherein the symbol R, R is as defined above the presence of 4-dimethylaminopyridine a dicyclohexylcargodllmide at temperature 10 to 20 ° C or with chloride or anhydride organic acids in the presence of of anhydrous pyridine at 20 to 60 ° C.
Description
Vynález se týká biologicky účinných esterů s pyrethroidní složkou v molekule a způsobu Jejich přípravy.The invention relates to biologically active esters with a pyrethroid component in the molecule and to a process for their preparation.
Podstatou předmětného vynálezu Jsou biologicky účinné estery s pyrethroidní složkou v molekule obecného vzorce I kde symbol R značí alkylskupinu s rovným či rozvětveným řetězeem s maximálně 4 ato kde halogen značí symbol X (chlór, brom).The present invention relates to biologically active esters with a pyrethroid component in the molecule of general formula I wherein the symbol R denotes a straight-chain or branched alkyl group with a maximum of 4 ato where halogen denotes the symbol X (chlorine, bromine).
Způsob přípravy biologicky účinných esterů s pyrethroidní složkou v molekule obecného vzorce I se vyznačuje tím, že se nechá reagovat hydroxysloučenina obecného vzorce II #A process for the preparation of biologically active esters with a pyrethroid component in a molecule of formula I is characterized in that a hydroxy compound of formula II is reacted.
kde symbol R , R má výše uvedený význam s organickou kyselincu.obecného vzorce III kde symbol X má výše uvedený význam za přítomnosti 4-dimethylaminopyrldinu a dicyklohexylkarbodiimidu při teplotě 10 až 20 °C nebo s chloridem či anhydrideta organické kyseliny za přítomnosti bezvodého pyridinu při 20 až 60 °C.wherein X, R is as defined above with an organic acid of formula III wherein X is as defined above in the presence of 4-dimethylaminopyridine and dicyclohexylcarbodiimide at 10 to 20 ° C or with an organic acid chloride or anhydride in the presence of anhydrous pyridine at 20 up to 60 ° C.
V dalším Je vynález blíže objasněn na příkladech provedení aniž se na tyto výlučně omezuje.In the following, the invention is further elucidated by means of exemplary embodiments without being limited thereto.
PříkladExample
0,12 g(O,55 mmol) 1-(2,2-dimethyl-6-chromenyl)-l-propanolu, 0,1 g (0,5 mmol) 3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropankarboxylové kyseliny, 0,1 g (0,5 mmol)'dicyklohexylkarbodiimidu a 0,005 g (0,05 nunol) Ν,Ν-dimethylamlnopyridinu bylo mícháno v 5 ml bezvodého diethyléteru při 15 až 20 °C po dobu 2 hodin. Vše bylo ponecháno při téže teplotě stát přes noc. Poté byla reakční směs zředěna diethyléterem, filtrována a filtrát byl postupně promyt 5 %-ním vodným roztokem kyseliny chlorovodíkové, nasyceným roztokem chloridu dosného ve vodě. Éterleká vrstva byla vysušena nad bezvodým síranemhořečnatým a z$ sníženého tlaku odpařena. Odparek byl pak dělen sloupcovou chromatografií na silikagelu s 8 hmot. % vody (eluční činidlo: petroéter obsahující až 20 obj. % diethyléteru). Bylo získáno 0,13 g (65 %) l-(2,2-dimethyl-6-chromenyl) propylesteru 3-(2,2-dichlorethenyl)-2,2-dimethylcýklopropankarboxylové kyseliny. IČ analýza (CCI^, 5 %) :1726,1712( CO ester.),1616,1493( arom.),1650,1641( C-C),1614( C-C konj.),1390,1378 1378( aCH3)cm-1. MS analýza: 408/10/12 /M+/,(Cgg^Cl^),393/5/7{C^H^Cl^),201 (C14H17O),185(C13H13O),144(C1oH0O).0.12 g (0.55 mmol) of 1- (2,2-dimethyl-6-chromenyl) -1-propanol, 0.1 g (0.5 mmol) of 3- (2,2-dichloroethenyl) -2, 2-Dimethylcyclopropanecarboxylic acid, 0.1 g (0.5 mmol) of dicyclohexylcarbodiimide and 0.005 g (0.05 mmol) of β, β-dimethylaminopyridine were stirred in 5 ml of anhydrous diethyl ether at 15 to 20 ° C for 2 hours. Everything was left to stand overnight at the same temperature. Then, the reaction mixture was diluted with diethyl ether, filtered, and the filtrate was washed successively with 5% aqueous hydrochloric acid solution, saturated brine. The ether layer was dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was then separated by column chromatography on silica gel with 8 wt. % water (eluent: petroether containing up to 20% by volume of diethyl ether). 0.13 g (65%) of 3- (2,2-dichloroethenyl) -2,2-dimethylcyclopropanecarboxylic acid 1- (2,2-dimethyl-6-chromenyl) propyl ester was obtained. IR analysis (CCl 3, 5%): 1726.1712 (CO ester.), 1616.1493 (arom.), 1650.1641 (CC), 1614 (CC conc.), 1390.1378 1378 ( a CH 3 ) cm- 1 . MS analysis: 408/10/12 / M + /, (Cl-CGG) 393/5/7 {C ^ H ^ Cl ^), 201 (C 14 H 17 O), 185 (C 13 H 13 O ), 144 (C 10 H 10 O).
Stejným způsobem byl připraven 1- (ě-(2-brom-l,l.dimethyl-3-ethoxypropoxy/fenylj propylester 3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropankarboxylové kyseliny. IČ analýza (uci4, ^)=1727,1710( OOéštěťJ, analýza :327/§(M+-G8iI902CI2).In the same manner was prepared 1- (E- (2-bromo-3-l.dimethyl ethoxypropoxy / -phenyl propyl 3- (2,2-dichloroethenyl) -2,2-dimethylcyclopropane acid. IR analysis (UCI 4 ^ ) = 1727.1710 (EI, analysis: 327 / § (M + -G 8 iI 9 0 2 Cl 2 ).
Biologické účinky byly zkoušeny na roztočí Tetranychus urticae, kde· bylo zjištěno ovlivnění jeho ogeneze a líhnivosti. Tak například pro 1“(2,2-dimethyl-6-chromenyl) propyleeter 3-(2,2-díchlorethenyl)”2,2dimethylcyÍklopropankarboxyiové kyseliny při kon -The biological effects were tested on the mite Tetranychus urticae, where it was found to affect its ogenesis and hatchability. For example, for 1 "(2,2-dimethyl-6-chromenyl) propyl ether of 3- (2,2-dichloroethenyl)" 2,2-dimethylcyclopropanecarboxylic acid at con-
centraci 10~^ obj.% v acetonu a kontaktní aplikaci 5 ul na listy fazole nakladly 12 svilušek během 96 hodin 4 vyjíčka. Po 7 dnech byly 3 z nich mrtvé. Pro 1- ^4(2-brom-l,l-dimethyl~3-ethoxypropoxy/fenylj propylester 3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropankarboxylové kyseliny při koncentraci 10~^obj.% 13 svilušek nenakladlo žádné vajíčko. Pro srovnání nakladlo 12 svilušek za stejnou dobu na listy ošetřené pouze acetonem 26 vxjíček, ze kterých se po 7 dnech líhly nymfy.concentration of 10% by volume in acetone and contact application of 5 .mu.l to the bean leaves loaded 12 mites in 96 hours. After 7 days, 3 of them were dead. For 3- (4-bromo-1,1-dimethyl-3-ethoxypropoxy) phenyl] propyl ester of 3- (2,2-dichloroethenyl) -2,2-dimethylcyclopropanecarboxylic acid at a concentration of 10% by volume, 13 mites did not charge any For comparison, 12 mites were placed on leaves treated with acetone only on 26 eggs, from which nymphs hatched after 7 days.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS8732A CS268082B1 (en) | 1987-01-04 | 1987-01-04 | Biologically active esters with pyrethroid component in molecule and method of their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS8732A CS268082B1 (en) | 1987-01-04 | 1987-01-04 | Biologically active esters with pyrethroid component in molecule and method of their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CS3287A1 CS3287A1 (en) | 1989-08-14 |
CS268082B1 true CS268082B1 (en) | 1990-03-14 |
Family
ID=5331800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS8732A CS268082B1 (en) | 1987-01-04 | 1987-01-04 | Biologically active esters with pyrethroid component in molecule and method of their preparation |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS268082B1 (en) |
-
1987
- 1987-01-04 CS CS8732A patent/CS268082B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS3287A1 (en) | 1989-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3928990A1 (en) | METHOD FOR PRODUCING (ALPHA) -FLUOROACRYLIC ACID DERIVATIVES | |
CS268082B1 (en) | Biologically active esters with pyrethroid component in molecule and method of their preparation | |
DE2318852A1 (en) | 7-ACYLAMIDO-3-HALOGEN-3-METHYL-CEPHAM4-CARBONIC ACID COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
DE2322655A1 (en) | CRYSTALLINE PROSTANIC ACID ESTER | |
DE69604541T2 (en) | DTPA derivatives modified with non-ester formation and processes for their preparation | |
DE2604283C2 (en) | Process for the preparation of 1,2-diacyl-3-glycerylphosphorylcholines | |
DE3789064T2 (en) | Process for the preparation of cyclopropanecarboxylic acid derivatives substituted in position 3 by a halogenated saturated chain. | |
DE2033357C3 (en) | Palmitoyl-propandioKl 3) -phosphoric acid-S-trimethylaminophenyl ester and process for its preparation | |
DE69002504T2 (en) | Optical separation of a carboxylic acid. | |
Huang et al. | Synthesis of acyl (phenylselanyl) methylidene (triphenyl)-λ 5-arsanes and their Wittig-type reactions | |
Stanacev et al. | SYNTHESIS OF DIPALMITOYL-l-α-GLYCEROPHOSPHORIC ACID DERIVATIVES, AS POSSIBLE INTERMEDIATES FOR SYNTHESIS OF GLYCERYLPHOSPHATIDES | |
DE68918357T2 (en) | Process for the production of optically active amino acid. | |
EP0222172B1 (en) | N-glycolylneuraminic acid derivative | |
CH518950A (en) | 1-beta-d-arabinofuranosylcytosine-2 and 3-phosphates | |
EP0110329B1 (en) | Process for the production of alpha-vinyl propionic acid esters | |
EP0067408B1 (en) | Process for the preparation of tetronic acid | |
DE2206849C2 (en) | Process for the resolution of 2- (2β-benzyloxymethyl-3α-hydroxy-4-cyclopentene-1α-yl) -acetic acid | |
DE69303333T2 (en) | Substituted benzoate derivatives | |
DE2409971C3 (en) | 5-cholesteric derivatives and process for their preparation | |
CH677662A5 (en) | 4-methoxy:naphthyl-3-buten-2-one prodn. | |
Nagatsugi et al. | Synthesis of ω-fluorinated octanoic acid and its β-substituted derivatives | |
DE2303612C3 (en) | Process for the production of prostaglandins | |
RU1249913C (en) | Method of obtaining substituted dimethylvinylphosphates | |
US2988568A (en) | Dibenzo cycloheptadiene carboxylic acid compounds and process of making same | |
CS261142B1 (en) | 4-(alkoxyalkoxy)phenylalkanoles with halogen in alkoxy group and their esters and method of their preparation |